BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9127631)

  • 21. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202.
    Datta B; Min W; Burma S; Lengyel P
    Mol Cell Biol; 1998 Feb; 18(2):1074-83. PubMed ID: 9448005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.
    D'Souza S; Xin H; Walter S; Choubey D
    J Biol Chem; 2001 Jan; 276(1):298-305. PubMed ID: 11013253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of growth by p205: a nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation.
    Dermott JM; Gooya JM; Asefa B; Weiler SR; Smith M; Keller JR
    Stem Cells; 2004; 22(5):832-48. PubMed ID: 15342947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.
    Wen Y; Yan DH; Spohn B; Deng J; Lin SY; Hung MC
    Cancer Res; 2000 Jan; 60(1):42-6. PubMed ID: 10646849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.
    Yan DH; Abramian A; Li Z; Ding Y; Wen Y; Liu TJ; Hunt K
    Biochem Biophys Res Commun; 2003 Mar; 303(1):219-22. PubMed ID: 12646190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-inducible p202 in the susceptibility to systemic lupus.
    Choubey D; Kotzin BL
    Front Biosci; 2002 May; 7():e252-62. PubMed ID: 11991834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p202 self-associates through a sequence conserved among the members of the 200-family proteins.
    Koul D; Obeyesekere NU; Gutterman JU; Mills GB; Choubey D
    FEBS Lett; 1998 Oct; 438(1-2):21-4. PubMed ID: 9821952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P202: an interferon-inducible negative regulator of cell growth.
    Choubey D
    J Biol Regul Homeost Agents; 2000; 14(3):187-92. PubMed ID: 11037051
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin-6 induces expression of Ifi202, an interferon-inducible candidate gene for lupus susceptibility.
    Pramanik R; Jørgensen TN; Xin H; Kotzin BL; Choubey D
    J Biol Chem; 2004 Apr; 279(16):16121-7. PubMed ID: 14764608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cell proliferation by the interferon-inducible 204 gene, a member of the Ifi 200 cluster.
    Lembo M; Sacchi C; Zappador C; Bellomo G; Gaboli M; Pandolfi PP; Gariglio M; Landolfo S
    Oncogene; 1998 Mar; 16(12):1543-51. PubMed ID: 9569021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains.
    Gribaudo G; Riera L; De Andrea M; Landolfo S
    FEBS Lett; 1999 Jul; 456(1):31-6. PubMed ID: 10452524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis.
    Xin H; D'Souza S; Jørgensen TN; Vaughan AT; Lengyel P; Kotzin BL; Choubey D
    J Immunol; 2006 May; 176(10):5863-70. PubMed ID: 16670293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase.
    Kuroda TS; Maita H; Tabata T; Taira T; Kitaura H; Ariga H; Iguchi-Ariga SM
    Gene; 2004 Sep; 340(1):83-98. PubMed ID: 15556297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
    Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
    Mercer WE; Shields MT; Amin M; Sauve GJ; Appella E; Romano JW; Ullrich SJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6166-70. PubMed ID: 2143581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.